Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Lipocine Inc., 3 years.
Lipocine Inc.
Director
Neuphoria Therapeutics Inc.
Director · President and CEO
Chief executive roles
Neuphoria Therapeutics Inc.
· Chief Executive Officer
Since July 2024
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Lipocine Inc. June 4, 202574.3%
-
Lipocine Inc. June 5, 202473.9%
-
Lipocine Inc. May 10, 202387.3%
Questions about Spyros Papapetropoulos
What boards is Spyros Papapetropoulos on?
Spyros Papapetropoulos sits on the boards of Lipocine Inc. and Neuphoria Therapeutics Inc.
What company is Spyros Papapetropoulos the CEO of?
Spyros Papapetropoulos has been Chief Executive Officer of Neuphoria Therapeutics Inc. since July 2024.
How long has Spyros Papapetropoulos served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.